How should the dose of levothyroxine (Unithroid) 75 µg be adjusted for a patient with a thyroid‑stimulating hormone level of 5.1 mIU/L?

Increase Unithroid to 88-100 µg

For a TSH of 5.1 mIU/L on Unithroid 75 µg, you should increase the dose by 12.5-25 µg (to 88-100 µg) and recheck TSH in 4-8 weeks. This TSH level indicates inadequate replacement requiring dose adjustment to achieve euthyroid status and prevent long-term complications of undertreated hypothyroidism.

Clinical Context and Dosing Strategy

A TSH of 5.1 mIU/L represents subclinical to mild overt hypothyroidism depending on your laboratory's reference range (typically 0.4-4.0 mIU/L). The patient is currently underdosed and requires upward titration.

Specific Dose Adjustment Algorithm

Based on established guidelines 1:

• Increment size: Increase by 12.5-25 µg increments 1
• Practical options:
  • Conservative: 88 µg daily (increase of 13 µg)
  • Standard: 100 µg daily (increase of 25 µg)
• Recheck timing: Measure TSH in 4-8 weeks after dose change 1

The choice between 88 µg vs 100 µg depends on:

• Age: If patient >50-60 years, favor smaller increment (88 µg) 1
• Cardiac status: If known coronary disease, use 88 µg 1
• Otherwise healthy adults: 100 µg is appropriate 1

Evidence-Based Dosing Guidance

Research demonstrates that pretreatment TSH levels predict final levothyroxine requirements 2. For subclinical hypothyroidism with TSH 4.0-8.0 mIU/L, initial doses of 25-75 µg are typically sufficient 1, but your patient is already on 75 µg and remains inadequately treated, necessitating the increase.

The guideline explicitly states: "Doses of 25-75 µg daily are usually sufficient for achieving euthyroid levels, with larger doses usually required for those presenting with higher TSH values" 1. Since 75 µg has not normalized TSH, progression to the next dose tier is indicated.

Administration Optimization

While adjusting the dose, ensure optimal absorption 1, 3:

• Timing: Take 30-60 minutes before breakfast with water, OR at bedtime 4 hours after last meal
• Avoid within 4 hours: Iron, calcium supplements, antacids, proton pump inhibitors 3
• Storage: 20-25°C (68-77°F), protected from light and moisture 1, 3

Recent evidence suggests that non-fasting administration with a 15% dose increase may be acceptable if fasting is burdensome 4, though this remains an alternative approach rather than standard practice.

Follow-Up Protocol

After dose adjustment 1:

1. Recheck TSH in 4-8 weeks (smaller dose changes may require 8 weeks to plateau)
2. Target TSH: 0.4-4.0 mIU/L (normal reference range) 1
3. Further adjustments: Continue 12.5-25 µg increments until TSH normalizes
4. Once stable: Monitor TSH every 6-12 months 1

Critical Pitfalls to Avoid

• Don't wait too long: Chronic undertreament increases cardiovascular risk and symptom burden
• Don't over-adjust: Excessive increases (>25 µg) risk overshooting, especially in elderly or cardiac patients 1
• Don't ignore absorption issues: If TSH remains elevated despite doses >200 µg/day, consider malabsorption, drug interactions, or non-compliance 1
• Don't target specific TSH within normal range: Unless pregnant, any value in normal range is acceptable 1

Special Considerations

If patient is pregnant or planning pregnancy: Increase dose immediately and target TSH <2.5 mIU/L in first trimester 1. Pregnancy increases levothyroxine requirements by approximately 30% 3.

If patient has cardiac disease: Use the smaller increment (88 µg) and monitor for anginal symptoms 1. The risk of cardiac events with minor over-replacement necessitates cautious titration 5.

If persistent symptoms despite normal TSH: After achieving euthyroid status, reassess for other causes rather than adding T3 therapy, which is not recommended 6.